Aardvark Therapeutics has followed up filings and speculation with a $94 million initial public offering, putting itself on ...

As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...

Dr Pandey shares key insights on dosing, monitoring, and patient education to sustain therapy and improve outcomes. Essential for cardiologists and PCPs!

Phase 2 obesity co-administration study with MC4R agonist bremelanotide plus GLP-1/GIP dual agonist tirzepatide Database lock completed Topline data readout ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

When Trova Wine and Market shut its doors last month after nearly five years in business in Dallas, owner Michelle Bonds pointed to an unexpected reason for closure: GLP-1 weight loss drugs like ...

Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...

And a review study published in Nutrients showed that yerba maté may help support energy levels, aid in weight loss by ...

Mouth and throat cancers are highly treatable if caught early, but they are often diagnosed at later stages because people ...

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

Injections like Wegovy have been hailed 'wonder-drugs' for their ability to help with a number of health conditions ...